MYOVIEW Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Myoview, and what generic alternatives are available?
Myoview is a drug marketed by Ge Healthcare and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in MYOVIEW is technetium tc-99m tetrofosmin kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m tetrofosmin kit profile page.
DrugPatentWatch® Generic Entry Outlook for Myoview
Myoview was eligible for patent challenges on February 9, 2000.
Indicators of Generic Entry
Summary for MYOVIEW
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MYOVIEW |
What excipients (inactive ingredients) are in MYOVIEW? | MYOVIEW excipients list |
DailyMed Link: | MYOVIEW at DailyMed |
Recent Clinical Trials for MYOVIEW
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Astellas Pharma Inc | Phase 2 |
GE Healthcare | Phase 4 |
US Patents and Regulatory Information for MYOVIEW
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | MYOVIEW | technetium tc-99m tetrofosmin kit | INJECTABLE;INJECTION | 020372-001 | Feb 9, 1996 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | MYOVIEW 30ML | technetium tc-99m tetrofosmin kit | INJECTABLE;INJECTION | 020372-002 | Jul 7, 2005 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MYOVIEW
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | MYOVIEW | technetium tc-99m tetrofosmin kit | INJECTABLE;INJECTION | 020372-001 | Feb 9, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MYOVIEW
See the table below for patents covering MYOVIEW around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2190484 | COMPOSITION RADIOPHARMACEUTIQUE AMÉLIORÉE (IMPROVED RADIOPHARMACEUTICAL COMPOSITION) | ⤷ Try a Trial |
Israel | 89779 | Ligands and cationic complexes thereof with technetium 99-m | ⤷ Try a Trial |
South Korea | 0149439 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MYOVIEW
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1178838 | 300736 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |